PP
Therapeutic Areas
Neuraxpharm Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Leriglitazon for X-ALD | X-linked Adrenoleukodystrophy (X-ALD) | Partnered Commercialization |
| Wearable Device for Epilepsy | Epilepsy Monitoring/Treatment | Commercial Launch |
| Sanofi Established Products Portfolio | Various CNS Disorders | Commercial Acquisition |
| Medical Cannabis Program | Various Qualifying Conditions | Pilot Commercial |